All News #Library
Others
Regimmune Licenses the Rights to Develop RGI-2001 To San Fu
01 Apr 2023 //
BUSINESSWIRE
REGiMMUNE Presented Positive Results of RGI-2001 in the Reduction
20 Dec 2022 //
BUSINESSWIRE
REGiMMUNE touts `compelling` data in stem call transplants
20 Dec 2022 //
FIERCEBIOTECH

Market Place
Sourcing Support